Acetyl Tetrapeptide-5 Mechanism of Action: How It Helps Reduce Under-Eye Puffiness

Acetyl Tetrapeptide-5 (CAS 820959-17-9) is a synthetic short-chain peptide with the amino acid sequence Ac-βAla-His-Ser-His-OH, and a molecular weight of approximately 492.49 Da. It is classified as a signaling peptide in cosmetic ingredient terminology, designed to modulate specific biological processes in the skin.

Eyeseryl® is a commercial trade name associated with Acetyl Tetrapeptide-5; the INCI name is Acetyl Tetrapeptide-5. Chemically, it carries an N-terminal acetylation modification, which is reported to improve peptide stability and skin penetration compared to unmodified short peptides. It is supplied as a white lyophilized powder for cosmetic manufacturing, most commonly incorporated into aqueous eye serums, gels and light emulsions.

As a cosmetic active, it is one of the more widely used cosmetic peptides for under-eye puffiness formulations, frequently included in premium anti-aging eye care lines alongside other peptides and circulation-supporting actives.

For bulk product specifications and supply information, visit the Acetyl Tetrapeptide-5 Powder product page.

The under-eye area is anatomically prone to visible puffiness: the skin is exceptionally thin, subcutaneous connective tissue is loose, and the capillary and lymphatic networks are dense and superficial. Multiple factors contribute to under-eye bag appearance, and no single ingredient addresses all types equally.

Transient morning puffiness is primarily linked to increased capillary permeability and interstitial fluid accumulation. It is often worsened by fatigue, sleep position, high salt intake and prolonged screen time, which disrupt local fluid balance and slow clearance.

Chronic under-eye bag appearance is driven by gradual loss of dermal elasticity. Glycation and oxidative stress damage collagen and elastin fibers in the periorbital dermis, reducing structural support and making underlying fluid and fat pads more visually prominent.

Many traditional decongestant or astringent ingredients carry irritation risk for delicate periorbital skin. Peptide-based actives are valued for their targeted mechanism and generally good tolerability, making them suitable for repeated use in this sensitive area.

The mechanism of action of Acetyl Tetrapeptide-5 is understood to be multifactorial, with three primary pathways discussed in published technical research and supplier data.

A core proposed benefit of Acetyl Tetrapeptide-5 is modulation of vascular permeability and support for fluid balance in periorbital tissue.

Under normal conditions, fluid and small molecules continuously leak from capillaries into the interstitial space and are recirculated. When this balance is disrupted by fatigue, inflammation or external stress, excess fluid accumulates in loose under-eye connective tissue, causing visible swelling.

In vitro studies on endothelial cell monolayers suggest that Acetyl Tetrapeptide-5 may reduce vascular permeability in a dose-dependent manner, by strengthening endothelial barrier function and limiting fluid extravasation into surrounding tissue. This proposed mechanism is particularly relevant to transient, morning-type under-eye puffiness driven by overnight fluid redistribution.

Acetyl Tetrapeptide-5 has been studied for a proposed ACE-related mechanism that may influence vascular permeability and fluid accumulation in the periorbital area.

Angiotensin-converting enzyme (ACE) is involved in local vascular tone regulation. In cutaneous tissue, local ACE activity is thought to influence periorbital vascular pressure and fluid balance. Supplier-published research indicates that Acetyl Tetrapeptide-5 may act as an ACE-inhibiting peptide, reducing the conversion of angiotensin I to angiotensin II at the local skin level.

The proposed downstream implications include potential effects on microcirculatory flow, vascular permeability and fluid balance in the periorbital area. This pathway is also associated with improvement in the appearance of vascular-type dark circles, by supporting venous blood flow and reducing stagnation of deoxygenated blood in superficial vessels.

Beyond fluid-related effects, Acetyl Tetrapeptide-5 is also reported to exhibit anti-glycation activity, addressing the longer-term structural component of under-eye bag formation.

Glycation is a non-enzymatic reaction in which sugar molecules bind to collagen and elastin, forming advanced glycation end-products (AGEs) that cause protein cross-linking. This makes dermal fibers stiff, brittle and less elastic. In thin under-eye skin, glycation-related elasticity loss reduces structural support, making fluid and fat pads more visible and contributing to permanent sagging-type eye bags.

Supplier-published technical data indicates that Acetyl Tetrapeptide-5 may inhibit the glycation reaction, helping to protect collagen fibers from cross-linking and preserve dermal extracellular matrix integrity. It is also reported to help protect antioxidant enzymes from glycation-induced inactivation, supporting the skin's endogenous antioxidant defense against periorbital oxidative stress. This effect is thought to contribute to longer-term maintenance of skin firmness and elasticity around the eyes.

Acetyl Tetrapeptide-5 has a molecular weight of approximately 492.49 Da, placing it below the commonly cited 500-Dalton threshold. However, the "500-Dalton rule" is a general heuristic rather than a guarantee of effective topical penetration. Actual delivery depends on peptide stability, formulation vehicle, concentration, skin barrier condition and other physicochemical properties.

The N-acetylation modification is also thought to improve skin permeation relative to unmodified peptides of similar size. For formulators, this means peptide concentration, formulation system and processing method all affect real-world performance, and penetration should be verified for each specific finished product.

Supplier-published in vivo testing reported visible improvement in some subjects as early as 15 days, with assessment continuing to 60 days. These findings should be interpreted as cosmetic ingredient data rather than independent clinical evidence.

Under-eye bags are not a single condition, and different types form through completely different mechanisms.

Edematous / fluid-type under-eye bags

This is the type most commonly associated with Acetyl Tetrapeptide-5 in cosmetic literature. It is characterized by temporary swelling that is typically worst in the morning, improves throughout the day, and is worsened by lack of sleep, high salt intake and fatigue. For this puffiness type, the proposed ACE-related and vascular permeability effects are directly relevant.

Aging / laxity-type under-eye bags

This type develops gradually with age, caused by loss of dermal collagen and elastin, weakening of the orbicularis oculi muscle and protrusion of orbital fat. It is permanent and does not fluctuate significantly throughout the day. Acetyl Tetrapeptide-5 may contribute through its reported anti-glycation and matrix-supporting effects, but cannot reverse already prolapsed fat pads or severe anatomical sagging.

Pigmentary dark circles

While not true eye bags, periorbital hyperpigmentation often coexists with puffiness. Acetyl Tetrapeptide-5 may help improve the appearance of blue-purple vascular dark circles by supporting microcirculation, but it does not directly affect melanin pigmentation.

To set realistic formulation expectations, it is equally important to clarify limitations:

It does not remove orbital fat pads.

It does not surgically correct structurally determined eye bags.

It does not directly treat melanin-based pigmentary dark circles.

It does not replace medical treatment for persistent periorbital edema caused by underlying health conditions.

All effects are cosmetic appearance-based and limited to the cutaneous layers of the periorbital region.

Acetyl Tetrapeptide-5 is primarily positioned for puffiness and fluid-related under-eye concerns, whereas other cosmetic peptides target expression lines, inflammation or extracellular-matrix remodeling.

For comprehensive eye care products, Acetyl Tetrapeptide-5 is often combined with other actives - for example, pairing it with a wrinkle-targeting peptide for a total anti-aging eye serum, or with caffeine for a multi-pathway decongestive formulation.

Understanding mechanism is only the first step; translating activity into a stable, effective product requires careful formulation design.

What pH Is Suitable for Acetyl Tetrapeptide-5?

Recommended formulation pH depends on the specific raw-material specification and supplier stability data. Formulators should confirm the acceptable pH range using the supplier's current Technical Data Sheet and conduct finished-product stability testing.

When Should Acetyl Tetrapeptide-5 Be Added?

Because peptide stability can be affected by prolonged exposure to elevated temperatures, formulators commonly add peptide actives during a controlled cooling stage. The appropriate addition temperature should be established through supplier-specific stability data rather than treated as a universal threshold.

Is Acetyl Tetrapeptide-5 Water-Soluble?

Acetyl Tetrapeptide-5 is commonly supplied for use in aqueous cosmetic systems, but actual solubility depends on raw-material form, concentration, carrier and formulation conditions. It is typically incorporated into the aqueous phase of emulsions and is not suitable for pure anhydrous oil systems.

How Should Acetyl Tetrapeptide-5 Powder Be Stored?

Raw powder should be stored sealed, protected from light and moisture, under refrigeration or frozen conditions for long-term storage. Finished products should be packaged in light-protective containers to maximize stability.

For a complete technical guide covering formulation parameters, stability testing and common pitfalls, continue reading our full Acetyl Tetrapeptide-5 formulation development guide.

Recommended use levels depend on the raw-material specification, carrier system and finished formulation. Supplier technical data for Eyeseryl-related preparations has reported use levels around 0.01%, but formulators should follow the specific supplier's TDS and validate stability and efficacy in the finished formulation.

Note that many commercial suppliers sell Acetyl Tetrapeptide-5 as a pre-diluted aqueous solution rather than pure powder. If using a solution form, calculate actual active peptide content based on solution concentration to avoid under-dosing.

What is Acetyl Tetrapeptide-5?

Acetyl Tetrapeptide-5 is a synthetic bioactive tetrapeptide used as a cosmetic ingredient, primarily in eye care products. It has the amino acid sequence Ac-βAla-His-Ser-His-OH and CAS registry number 820959-17-9.

Is Acetyl Tetrapeptide-5 the same as Eyeseryl?

Eyeseryl® is a commercial trade name associated with Acetyl Tetrapeptide-5. The official INCI name and general ingredient name is Acetyl Tetrapeptide-5.

How does Acetyl Tetrapeptide-5 work?

Current technical research suggests it works through three proposed pathways: an ACE-related mechanism that may influence local microcirculation, modulation of vascular permeability to reduce fluid accumulation, and anti-glycation activity to support dermal matrix integrity. Independent human clinical evidence remains limited.

Does Acetyl Tetrapeptide-5 work on all types of eye bags?

No. It is most relevant to fluid-type and puffiness-related under-eye appearance. It does not address severe structural eye bags caused by prolapsed orbital fat, nor does it treat melanin-based dark circles.

Can Acetyl Tetrapeptide-5 penetrate the skin?

Its molecular weight of ~492.49 Da falls below the commonly referenced 500-Dalton penetration threshold, but the 500-Dalton rule is a general heuristic, not a guarantee. Actual delivery depends on formulation, skin condition and product base.

Is Acetyl Tetrapeptide-5 suitable for eye serums?

Yes, it is well suited for eye serum formulations. It is commonly used in aqueous systems, generally well tolerated on delicate periorbital skin, and compatible with typical serum bases containing humectants and soothing ingredients.

What is CAS 820959-17-9?

CAS 820959-17-9 is the CAS registry number assigned to Acetyl Tetrapeptide-5, the standard chemical identifier for sourcing, regulatory documentation and ingredient labeling.

How should Acetyl Tetrapeptide-5 be sourced?

It should be sourced from reputable peptide manufacturers that provide batch-specific quality documentation including HPLC purity reports, LC-MS identity verification and a Certificate of Analysis. Buyers should verify purity grade, residual solvent levels and batch consistency before placing bulk orders.

Puig A, Antón JM, Pérez R, Mangues M. (2007). Eyeseryl® and Leuphasyl®: Synthetic Peptides as Advanced Cosmetic Actives. Journal of Cosmetic Science, 58(3), 289–299.

Lipotec S.A.U. (n.d.). Eyeseryl® Technical Datasheet: Acetyl Tetrapeptide-5. Barcelona, Spain: Lipotec Active Cosmetic Ingredients.

Cosmetic Ingredient Review (CIR) Expert Panel. (2021). Safety Assessment of Acetyl Tetrapeptide-5 as Used in Cosmetics. International Journal of Toxicology, 40(3_suppl), 5S–18S.

Bos J.D., Meinardi M.M.H. (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology, 9(3), 165–169.

Zhang L, et al. (2022). Anti-glycation and antioxidant activities of cosmetic oligopeptides: A structure-activity review. Journal of Cosmetic Dermatology, 21(11), 4587–4598.

Acetyl Tetrapeptide-5 is a widely used cosmetic peptide for under-eye puffiness care, with a proposed multi-pathway mechanism covering ACE-related activity, vascular permeability modulation and anti-glycation matrix protection. Its targeted activity profile and generally good tolerability make it a common active for premium eye care formulations.

Current evidence is strongest at the in vitro and supplier-study level; independent human clinical validation remains limited. Formulators and buyers should evaluate raw material quality, supplier documentation and formulation stability when developing products containing this ingredient.

HDM BIO supplies high-purity cosmetic-grade Acetyl Tetrapeptide-5 with full analytical documentation, suitable for formulation development and mass production.

To request a Technical Data Sheet, sample Certificate of Analysis or bulk quotation, visit the Acetyl Tetrapeptide-5 raw material product page.